Purchase Order 75N93021P01508
Award Date 9/24/21
Potential Completion Date 9/23/22
Potential Value $45K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sparks, MD 21152, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $13,237.18 on October 19, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion date is January 20, 2021. The source does not specify the equipment or supplies purchased under this order.</p>
- Becton, Dickinson and Company, operating through its BD Biosciences division, was awarded a $13,883.23 firm fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) on March 10, 2022, with a completion date of April 30, 2022. The contract covers pre-contract inspection and recertification services for an LSR Fortessa flow cytometry system, a critical research instrument used in biomedical analysis and infectious disease research. The work is to be performed...
- This purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is for a bridge service agreement for one quarter of service on 56 instruments in real-time systems. The $92,081.76 firm fixed price contract was awarded to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division, with period of performance from January 20, 2021 to May 4, 2021 in Bethesda,...
- Becton, Dickinson and Company, doing business as BD, has been awarded a $21,000 purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Whole Transcriptome Analysis reagent kits. The contract has a period of performance from September 14, 2023 through December 31, 2023. BD will deliver the requested reagent kits on a firm fixed price basis from its Franklin Lakes, New Jersey facility to support NIAID's research efforts. No...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $6,427.60 firm-fixed-price contract was awarded to Becton, Dickinson and Company (BD), a major manufacturer of medical devices, instruments, and diagnostic products. The contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of September 30, 2017. The contract does not have a...
- Becton, Dickinson and Company, doing business as BD, has been awarded a purchase order contract valued at approximately $13,924.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the terms of the contract, BD will provide BD Antibodies (AMBIS #2187100) to support NIH/NIAID's research efforts related to allergies and infectious diseases. Place of performance will be BD's facilities in Franklin Lakes, New Jersey, with work expected to be...
- This is a federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $253,503.78, is a firm-fixed-price delivery order that was awarded on June 6, 2016 with a completion date of September 1, 2016. The contract does not have a set-aside designation. BD, through its BD Biosciences division, is a manufacturer...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- On September 16, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order valued at $47,198.82 to Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, for BD Reagents. This firm fixed-price contract was awarded without a small business set-aside on a competitive basis. The award represents a purchase order action to procure reagents from BD, a global medical technology company specializing in flow cytometry, cell...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company, through its BD Biosciences division, for service contract work on laboratory equipment on April 1, 2023, with a ceiling value of $236,470.02. The order is firm fixed price with no set-aside applied. Performance takes place in North Bethesda, Maryland. The ultimate completion date is March 31, 2024.</p>